content

Novartis key multiple sclerosis product Gilenya approved in China

"It is exciting news for MS patients in China that Gilenya has received fast approval. The approval of Gilenya and the upcoming regulatory review...

Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For Spinal Muscular Atrophy

Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular...

Huge CPhI P MEC China a direct result of surging manufacturing

Organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets –...

TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform

TraceLink Inc., the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes, announced a partnership with Excellis Health Solutions...

A Powerful Pairing: Academia-Industry Collaborations for Pharmaceutical Innovation

Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not...

Top Three Considerations for Purchasing Antibodies

Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states. These tools, with their high...

Sale of Bosch Packaging Technology: CVC Capital Partners and Bosch reach an agreement

Bosch plans to sell its packaging machinery business, based in Waiblingen, to a newly incorporated entity managed by CVC Capital Partners (CVC). The company...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read